Advertisement

New Strategies and Challenges of PrEP in the COVID-19 Era


The Dialogue series is intended for healthcare clinicians and researchers, including infectious disease and HIV specialists. In this Dialogue, Dr Raphael J. Landovitz of the University of California Los Angeles and Dr E. Turner Overton of the University of Alabama at Birmingham will discuss new findings and challenges regarding HIV preexposure prophylaxis (PrEP), along with the impact of the COVID-19 pandemic on PrEP use in the US. Recent data presented by Dr Landovitz at AIDS 2020 regarding long-acting, injectable PrEP, will also be included in the discussion.

Featuring: 

Raphael J. Landovitz, MD

University of California Los Angeles

E. Turner Overton, MD

University of Alabama at Birmingham

When
September 09, 2020
Global
Venue
Virtual
Link

Advertisement

Hot topics


COVID Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

COVID Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.